Newsmeme!
Discover News you didn't know existed
Pathogenesis
News
MedImmune Advances Asthma Program With Start Of Phase 2 Clinical Trial For Antibody Targeting IL-5 Receptor
Published December 5, 2008, 3:15 am, Medical News Today
MedImmune announced that it has initiated a Phase 2 clinical trial in patients with chronic asthma to determine the safety of subcutaneous dosing of a humanized monoclonal antibody (MAb) that targets the interleukin-5 receptor (IL-5R).
Tags
No tags found at this time. Be the first to tag this news item, learn more.
Imagery
Related Pathogenesis Stories
From Various News Sources
MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial ... - Phramalive.com
GAITHERSBURG, Md., December 04, 2008 /PRNewswire/ -- MedImmune today announced that it has initiated a Phase 2 clinical trial in patients with chronic asthma to determine the safety of subcutaneous dosing of a humanized monoclonal antibody (MAb) that ...
Related Social Bookmarks
None found at this time.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |